Deal Flow
Letter · prints on one page
Transaction tear sheetData as of Nov 7, 2026
M&A · Healthcare · Services-Misc Health & Allied Services, NEC

TPG Cannes Aggregation, L.P. to acquire Convey Health Solutions Holdings, Inc.

Announced Jun 21, 2022 · Closed Oct 7, 2022

Deal value$1.10BEV $1.10B
Premium143.0%To unaffected price
EV / Adj. EBITDA22.1x3.1x EV / Revenue
ConsiderationAll cash$10.50 per share

Transaction

Acquirer
TPG Cannes Aggregation, L.P.
Target
Convey Health Solutions Holdings, Inc.
Buyer type
Private equity
Offer price per share
$10.50
Enterprise value
$1.10B
Status
Closed Oct 7, 2022

Deal protections

Break fee (target pays)
$24.0M · 2.2%
Reverse fee (buyer pays)
$50.0M · 4.5%
Go-shop
No-shop
Financing
No financing condition

Advisors

To the acquirer
Not disclosed
To the target
Centerview
Centerview fee
$8.0M

Sector context · Healthcare

Comparable deals
45 in the prior 24 months
Premium
143.0% vs. 46.0% sector median
EV / Adj. EBITDA
22.1x vs. 19.3x sector median
Break fee
2.2% vs. 3.4% sector median

Timeline

  1. AnnouncedJun 21, 2022
  2. Proxy filedJul 25, 2022
  3. Definitive proxySep 1, 2022
  4. Shareholder vote—
  5. ClosedOct 7, 2022

Valuation · fairness opinions

Trading comparables$6.00$9.45
Premiums paid$5.65$6.70
Discounted cash flow$7.00$11.65
Future share price$5.00$9.05
Offer $10.50

Implied value per Convey Health Solutions Holdings, Inc. share by analysis, from Centerview · DCF discount rate 10%–12%.

Sources
  • 8-K · Jun 21, 2022

Adj. EBITDA is operating income + D&A + impairment, restructuring, deal costs and stock compensation, less any large gain on a sale, last twelve months, from the target's filings. Calculated by Castle, so it can differ from a bank's adjusted figure.

Prepared with Castle from public SEC EDGAR filings. Figures are extracted automatically; verify against the source documents. Not investment advice.